Resmed INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NYSE
RMD
Resmed INCResMed Inc. announced robust financial results for fiscal year 2026, with a 10% increase in net revenue and a 13% rise in gross profit, alongside strategic acquisitions to bolster its healthcare offerings.
NYSE
RMD
Resmed INCResMed Inc. announced a robust fiscal year 2025, with significant revenue and profit increases driven by its digital health and sleep & breathing solutions.
NYSE
RMD
Resmed INCResMed Inc. released its annual report for fiscal year 2024, showcasing a robust 11% increase in net revenue and significant growth across its Sleep and Respiratory Care and Software as a Service (SaaS) segments.